作者: H. Shaw Warren , Robert L. Danner , Robert S. Munford
DOI: 10.1056/NEJM199204233261711
关键词:
摘要: Several monoclonal antibodies directed against bacterial lipopolysaccharide (endotoxin) are being developed for the adjunctive treatment of gram-negative sepsis. Two these, E5 (XOMA, Berkeley, C...